Imaging: Nanoscopy at low light intensities shows its potential

  1. Travis J Gould  Is a corresponding author
  2. Joerg Bewersdorf  Is a corresponding author
  1. Yale University School of Medicine, United States

The availability of fluorescence microscopes that can image sub-cellular structures labelled by fluorescent markers in living cells has provided fresh insights into a variety of cellular processes and functions. For most of the 20th century the resolution of such lens-based microscopes was limited by diffraction of the light used to form the image. This diffraction limit is about half the wavelength of the light, which means that an optical microscope cannot achieve a resolution any better than about 250 nm. In 1994, however, Stefan Hell and Jan Wichmann predicted that the diffraction limit could be beaten by a new form of fluorescence microscopy called stimulated emission depletion (STED) microscopy (Hell and Wichmann, 1994). This approach and related techniques are now routinely used to image fixed and living cells with a resolution of better than 100 nm (Gould et al., 2012). However, the high light intensities needed for these forms of ‘nanoscopy’, combined with relatively slow imaging speeds, can be problematic when imaging living samples. Now, in eLife, Hell and co-workers report that a new fluorescent marker called rsEGFP2 allows them to image living cells at low light intensities some 25–250 times faster than was possible previously (Grotjohann et al., 2012).

In fluorescence microscopy, fluorescent markers (also known as fluorophores) are excited by a bright light source, often a laser. After a short time the excited fluorophore returns to its electronic ground state by releasing a fluorescence photon, and an image of the sample can be built up by detecting these photons. Whereas the resolution of a conventional microscope is determined by the optics of the instrument, the resolution achievable with a fluorescence nanoscope depends on both the optics and the properties of the fluorophore. The diffraction limit is overcome by switching the fluorophores in the sample on and off (Hell, 2009). In STED microscopy, for example, a second laser is used to transfer the fluorophore from the excited state to the ground state without fluorescing. By focusing the second laser (the depletion laser) in a ring shape, and then overlaying this pattern on the first laser, it is possible to effectively switch off all of the fluorophores, apart from those very close to the centre of the ring (where the intensity of the depletion laser is negligible; Figure 1). This targeted switching approach thereby creates a sub-diffraction sized region from which fluorescence can be emitted. A ‘super-resolution’ image is built up by scanning the two laser foci across the sample and recording the fluorescence signal.

Comparison of three forms of fluorescence microscopy. In conventional fluorescence microscopy (top), a single laser (shown here in blue) is used to excite green fluorescent protein (GFP) or some other fluorophore, and the resulting fluorescence is detected. The resolution is determined by the size of region in which the GFP is excited (shown in green) and corresponds to the diffraction-limited laser focus size. In stimulated emission depletion (STED) nanoscopy (middle), a second ring-shaped laser focus (shown here in orange) is used to transfer excited GFP molecules at the periphery of the excitation focus back to the ground state without fluorescing: the size of the region in which the GFP can still fluoresce is smaller than in conventional fluorescence microscopy and is no longer limited by the laser focus size. In RESOLFT nanoscopy with rsEGFP2 (bottom), inactive fluorophores (shown as black molecular structures) are first activated by a violet laser focus. A second blue ring-shaped laser focus then continuously excites activated fluorophores until they have switched back to the inactive state. After these two steps, a conventional blue laser focus is used to illuminate the remaining active molecules and the resulting fluorescence is detected. Similar to STED nanoscopy, the size of the region in which rsEGFP2 can still fluoresce is not limited by diffraction. Typical wavelengths, laser intensities, and illumination times are shown for each laser. The period during which fluorescence is detected by all three methods is comparable (∼1 to 10 μs). Note that GFPs are not shown to scale. EGFP is enhanced GFP.

The resolution of STED microscopes is given by the equation Δr ≈ λ/(2NA(1+Imax/Isat)1/2), where λ is the wavelength of the depletion laser, NA is the numerical aperture of the objective lens, Imax is the peak intensity of the depletion laser, and Isat is the saturation intensity of the fluorophore (that is, the intensity at which 50% of the fluorescence is depleted; Hell, 2009). The size of the fluorescent region can, in principle, be made arbitrarily small by increasing the peak intensity of the depletion laser Imax or by using a fluorophore with a low saturation intensity Isat, which can be achieved by using a fluorophore with a long excited state lifetime Tfluor (because Isat is inversely proportional to Tfluor). Due to the short lifetimes of most fluorophores, which are on the order of nanoseconds, the saturation intensity Isat is typically ∼104 kW/cm2 (Hell, 2009). This means that the peak intensity of the depletion laser Imax needs to be higher than ∼105 kW/cm2 to push the resolution significantly below the diffraction limit. In addition to limiting laser choice, such high intensities raise concerns that living specimens could suffer long-term photodamage.

Targeted switching can, in principle, be used with any reversibly switchable optical transition, not just stimulated emission, as described by the RESOLFT principle (Hell et al., 2003). By choosing a transition with a lifetime that is much longer than Tfluor, it is possible to push the resolution well below the diffraction limit with laser intensities much lower than those used in STED microscopy. One variant of RESOLFT nanoscopy has recently come to fruition in biological imaging experiments using fluorescent proteins that can be reversibly switched between two states (Brakemann et al., 2011; Grotjohann et al., 2011; Testa et al., 2012).

These approaches require three illumination steps: one for activation, one for targeted deactivation and one for readout of the remaining activated probe molecules. For example RESOLFT nanoscopy using rsEGFP (reversibly switching enhanced green fluorescent protein) works as follows: first, a diffraction-limited violet laser focus is used to activate the fluorophores (i.e., switch them to a state that is capable of fluorescence). Second, a ring-shaped blue laser focus repeatedly excites the activated molecules to fluoresce, although this fluorescence is not recorded, and eventually deactivates them (i.e., switches them to a fluorescence incapable state). Laser light of the same colour, but conventionally focused, is then used to excite the remaining activated fluorophores at the centre of the ring and the fluorescence from this sub-diffraction area is detected. This three-step process is repeated for every pixel of the super-resolution image. Due to the long lifetime of the activated state, low intensities of the ring-shaped focus of Imax ∼1 to 10 kW/cm2 have been sufficient to achieve sub-100 nm resolution. However, the long pixel dwell times required by the slow switching kinetics of the fluorophore, rsEGFP, have led to image acquisition times of up to about an hour in the past (Grotjohann et al., 2011).

Now Hell and co-workers—including Tim Grotjohann and Ilaria Testa of the Max Planck Institute for Biophysical Chemistry as joint first authors, and Stefan Jakobs as joint corresponding author—report that they have modified this protein to make a new fluorophore called rsEGFP2 with a shorter switching time and improved resistance to switching fatigue (Grotjohann et al., 2012). This has allowed them to image various structures inside living cells 25–250 times faster than previously reported. Importantly, the relatively low laser intensities (∼1 to 80 kW/cm2 in a laser scanning configuration in which every point of the sample is illuminated for only a fraction of the frame acquisition time) needed to switch off the fluorescence mean that this approach exposes samples to the lowest radiation doses of all the nanoscopy techniques demonstrated to date.

Compared to STED nanoscopy, the current approach to RESOLFT nanoscopy requires additional activation and deactivation steps before the actual fluorescence can be recorded (see Figure 1). These steps inherently add overhead to the imaging process, and this slows down data acquisition. However, the advent of new fluorescent proteins such as rsEGFP2 extends RESOLFT nanoscopy with photoswitchable markers to faster live-cell imaging and holds great promise for future biological applications. The use of low light intensities results in reduced phototoxicity and is likely to allow imaging over extended time periods. Temporal resolution can be further improved using parallelization techniques and, if combined with faster switching rates, this should lead to video-rate RESOLFT nanoscopy over large fields of view.


Article and author information

Author details

  1. Travis J Gould

    Department of Cell Biology and the Kavli Institute for Neuroscience, Yale University School of Medicine, New Haven, United States
    For correspondence
    Competing interests
    No competing interests declared.
  2. Joerg Bewersdorf

    Departments of Cell Biology and Biomedical Engineering, and the Kavli Institute for Neuroscience, Yale University School of Medicine, New Haven, United States
    For correspondence
    Competing interests
    JB discloses significant financial interest in Vutara, Inc.

Publication history

  1. Version of Record published: December 31, 2012 (version 1)


© 2012, Gould and Bewersdorf

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.


  • 491
    Page views
  • 51
  • 5

Article citation count generated by polling the highest count across the following sources: Crossref, Scopus, PubMed Central.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Travis J Gould
  2. Joerg Bewersdorf
Imaging: Nanoscopy at low light intensities shows its potential
eLife 1:e00475.
  1. Further reading

Further reading

    1. Structural Biology and Molecular Biophysics
    Eshwar R Tammineni, Lourdes Figueroa ... Eduardo Rios
    Research Article

    Calcium ion movements between cellular stores and the cytosol govern muscle contraction, the most energy-consuming function in mammals, which confers skeletal myofibers a pivotal role in glycemia regulation. Chronic myoplasmic calcium elevation (“calcium stress”), found in malignant hyperthermia-susceptible (MHS) patients and multiple myopathies, has been suggested to underlie the progression from hyperglycemia to insulin resistance. What drives such progression remains elusive. We find that muscle cells derived from MHS patients have increased content of an activated fragment of GSK3β — a specialized kinase that inhibits glycogen synthase, impairing glucose utilization and delineating a path to hyperglycemia. We also find decreased content of junctophilin1, an essential structural protein that colocalizes in the couplon with the voltage-sensing CaV1.1, the calcium channel RyR1 and calpain1, accompanied by an increase in a 44 kDa junctophilin1 fragment (JPh44) that moves into nuclei. We trace these changes to activated proteolysis by calpain1, secondary to increased myoplasmic calcium. We demonstrate that a JPh44-like construct induces transcriptional changes predictive of increased glucose utilization in myoblasts, including less transcription and translation of GSK3β and decreased transcription of proteins that reduce utilization of glucose. These effects reveal a stress-adaptive response, mediated by the novel regulator of transcription JPh44.

    1. Cell Biology
    2. Structural Biology and Molecular Biophysics
    Janice M Reimer, Morgan E DeSantis ... Andres E Leschziner
    Research Advance Updated

    The lissencephaly 1 protein, LIS1, is mutated in type-1 lissencephaly and is a key regulator of cytoplasmic dynein-1. At a molecular level, current models propose that LIS1 activates dynein by relieving its autoinhibited form. Previously we reported a 3.1 Å structure of yeast dynein bound to Pac1, the yeast homologue of LIS1, which revealed the details of their interactions (Gillies et al., 2022). Based on this structure, we made mutations that disrupted these interactions and showed that they were required for dynein’s function in vivo in yeast. We also used our yeast dynein-Pac1 structure to design mutations in human dynein to probe the role of LIS1 in promoting the assembly of active dynein complexes. These mutations had relatively mild effects on dynein activation, suggesting that there may be differences in how dynein and Pac1/LIS1 interact between yeast and humans. Here, we report cryo-EM structures of human dynein-LIS1 complexes. Our new structures reveal the differences between the yeast and human systems, provide a blueprint to disrupt the human dynein-LIS1 interactions more accurately, and map type-1 lissencephaly disease mutations, as well as mutations in dynein linked to malformations of cortical development/intellectual disability, in the context of the dynein-LIS1 complex.